Psychological Distress Across the Trajectory of Hematological Malignancies: A Systematic Review of Prevalence, Risk Factors, and Clinical Impact
Psycho-Oncology · 2026-11 · 35 (11)
DOI: 10.1002/pon.70653 ↗At a glance
Systematische Übersicht in Psycho-Oncology, published online on 2026-11-14. Written by Huiyi Zhang and 8 co-authors. Institution: Nursing Department, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China. Major MEDLINE topics: Hematologic Neoplasms, Psychological Distress, Stress, Psychological. 79 references. Funded by: The Major Special Project of Health Science Research in Hunan Province, The Independent Exploration and Innovation Project for Graduate Students of Central South University.
Abstract (original language)
Objective
This systematic review synthesizes evidence on psychological distress (PD) prevalence, associated factors, and clinical correlates across the disease and treatment continuum.
Methods
Systematic search of PubMed, Embase, Web of Science, and the Cochrane Library (up to April 12, 2026). Methodological quality was assessed using JBI, NOS, and NIH tools. A narrative synthesis and an exploratory cross‐study Normalized Distress Index (NDI, 0‐10 scale) were used to summarize heterogeneous outcome measures across seven clinical phases, supplemented by construct‐specific sensitivity analyses.
Results
Sixty studies were included ( N = 31,090 patients across all cohorts; N = 13,291 confirmed hematological malignancy patients). PD prevalence varied substantially across instruments, thresholds, and disease stages (ranging from 21.9% to 66.0% on the Distress Thermometer, 15.0%–70.0% for anxiety, and 12.0%–76.0% for depression on the HADS). Cross‐study phase‐specific synthesis revealed a fluctuating “multi‐peak” pattern: on general distress measures, the aggregated index was highest during consolidation/maintenance therapy (NDI = 4.95 ± 0.35) and at diagnosis (NDI = 4.34 ± 1.90), with a further elevation during hematopoietic stem cell transplantation (HSCT) (NDI = 4.11) and lowest during post‐treatment follow‐up (NDI = 1.28 ± 0.31) and long‐term survivorship (NDI = 2.21 ± 0.73); on symptom‐specific measures, anxiety and depression peaked during HSCT (HADS‐A NDI = 2.66; HADS‐D NDI = 2.16). Key factors associated with PD included younger age, female sex, physical symptom burden, financial toxicity, and unmet spiritual/social needs. PD was consistently associated with poorer quality of life, and functional impairment, while limited retrospective evidence suggested a potential association with survival outcomes.
Conclusion
PD represents a significant, phase‐specific burden across the hematological malignancy continuum. Informed by the phase‐specific risk factors identified in this review, we propose a hypothesis‐generating, stepped‐care management framework anchored by routine Distress Thermometer screening, integrating financial navigation, spiritual care, and dyadic family‐centered support for future clinical validation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Nursing Department, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Xiangya School of Nursing, Central South University, Changsha, Hunan, China.
- School of Psychological Sciences, Monash University, Melbourne, Australia.
- The Education University of Hong Kong, Hong Kong, China.
ORCID profiles: Huiyi Zhang, Jie Zhu, Yinglong Duan, Jiayi Zhu, Lijun Li, Jianfei Xie, Andy S K Cheng
Funding
- The Major Special Project of Health Science Research in Hunan Province
- The Independent Exploration and Innovation Project for Graduate Students of Central South University
Cite
APA
Zhang, H., Zhu, J., Duan, Y., Zhu, J., Lu, Z., Qin, D., Li, L., Xie, J., & Cheng, A. S. K. (2026). Psychological Distress Across the Trajectory of Hematological Malignancies: A Systematic Review of Prevalence, Risk Factors, and Clinical Impact. Psycho-Oncology, 35(11). https://doi.org/10.1002/pon.70653
Vancouver
Zhang H, Zhu J, Duan Y, Zhu J, Lu Z, Qin D, et al. Psychological Distress Across the Trajectory of Hematological Malignancies: A Systematic Review of Prevalence, Risk Factors, and Clinical Impact. Psycho-Oncology. 2026;35(11). doi:10.1002/pon.70653
BibTeX
@article{Zhang2026,
author = {Zhang, Huiyi and Zhu, Jie and Duan, Yinglong and Zhu, Jiayi and Lu, Zitong and Qin, Dongren and Li, Lijun and Xie, Jianfei and Cheng, Andy S K},
title = {Psychological Distress Across the Trajectory of Hematological Malignancies: A Systematic Review of Prevalence, Risk Factors, and Clinical Impact},
journal = {Psycho-Oncology},
year = {2026},
volume = {35},
number = {11},
doi = {10.1002/pon.70653}
}
EUVIMED